Novo stocks make biggest jump in two years
Novo Nordisk’s shares rose 9.2% to 331.55 kroner on Tuesday after the FDA approved their Wegovy pill for sale in the USA. This new daily pill form allows patients to achieve the same weight loss as the original injection, broadening the market appeal, especially for those with needle phobia, according to CEO Mike Doustdar. Market […]